{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T18:17:23Z","timestamp":1778696243952,"version":"3.51.4"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ejogrb.2024.07.054","type":"journal-article","created":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T15:53:53Z","timestamp":1722095633000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Calcium versus cabergoline for prevention of ovarian hyperstimulation syndrome: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"301","author":[{"given":"Saeed","family":"Baradwan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dania","family":"AlJaroudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Agdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bandr","family":"Hafedh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanin Hassan","family":"Abduljabbar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussein","family":"Sabban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabigah","family":"Alzawawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasser","family":"Alsaad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majed Saeed","family":"Alshahrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah","family":"Idriss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rayan","family":"AlSghan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Asiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afnan","family":"Baradwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alaa","family":"Edrees","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Abu-Zaid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejogrb.2024.07.054_b0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ogrm.2022.10.002","article-title":"Ovarian hyperstimulation syndrome: a review of recent practices","volume":"33","author":"Ali","year":"2023","journal-title":"Obstet Gynaecol Reprod Med"},{"issue":"3","key":"10.1016\/j.ejogrb.2024.07.054_b0010","first-page":"248","article-title":"ovarian hyperstimulation syndrome: A narrative review of its pathophysiology, risk factors, prevention, classification, and management","volume":"43","author":"Namavar Jahromi","year":"2018","journal-title":"Iran J Med Sci"},{"issue":"4","key":"10.1016\/j.ejogrb.2024.07.054_b0015","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/uog.14684","article-title":"Ovarian hyperstimulation syndrome: pathophysiology, staging, prediction and prevention","volume":"45","author":"Nastri","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ejogrb.2024.07.054_b0020","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1093\/oxfordjournals.humrep.a138598","article-title":"Early and late presentation of the ovarian hyperstimulation syndrome: two distinct entities with different risk factors","volume":"9","author":"Lyons","year":"1994","journal-title":"Hum Reprod"},{"issue":"5","key":"10.1016\/j.ejogrb.2024.07.054_b0025","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0015-0282(00)00492-1","article-title":"Distinction between early and late ovarian hyperstimulation syndrome","volume":"73","author":"Mathur","year":"2000","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.ejogrb.2024.07.054_b0030","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S1472-6483(10)60042-9","article-title":"Update on prediction and management of OHSS. A modern classification of OHSS","volume":"19","author":"Golan","year":"2009","journal-title":"Reprod Biomed Online"},{"issue":"9","key":"10.1016\/j.ejogrb.2024.07.054_b0035","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1093\/humrep\/dew149","article-title":"Ovarian hyperstimulation syndrome: review and new classification criteria for reporting in clinical trials","volume":"31","author":"Humaidan","year":"2016","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.ejogrb.2024.07.054_b0040","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0015-0282(16)55188-7","article-title":"Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment","volume":"58","author":"Navot","year":"1992","journal-title":"Fertil Steril"},{"issue":"7","key":"10.1016\/j.ejogrb.2024.07.054_b0045","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1210\/jcem.87.7.8651","article-title":"Human chorionic gonadotropin-induced ovarian hyperstimulation syndrome is associated with up-regulation of vascular endothelial growth factor","volume":"87","author":"Wang","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ejogrb.2024.07.054_b0050","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/humupd\/3.3.255","article-title":"The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome","volume":"3","author":"Rizk","year":"1997","journal-title":"Hum Reprod Update"},{"issue":"4","key":"10.1016\/j.ejogrb.2024.07.054_b0055","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/humupd\/dmn008","article-title":"Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome","volume":"14","author":"Soares","year":"2008","journal-title":"Hum Reprod Update"},{"issue":"12","key":"10.1016\/j.ejogrb.2024.07.054_b0060","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1177\/1933719116672588","article-title":"The Ovarian Renin-Angiotensin System (OVRAS): A major factor in ovarian function and disease","volume":"23","author":"Palumbo","year":"2016","journal-title":"Reprod Sci"},{"issue":"2","key":"10.1016\/j.ejogrb.2024.07.054_b0065","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0015-0282(99)00206-X","article-title":"Prognostic importance of serial cytokine changes in ascites and pleural effusion in women with severe ovarian hyperstimulation syndrome","volume":"72","author":"Chen","year":"1999","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.ejogrb.2024.07.054_b0070","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0015-0282(98)00447-6","article-title":"Serum vascular endothelial growth factor concentrations in in vitro fertilization cycles predict the risk of ovarian hyperstimulation syndrome","volume":"71","author":"Agrawal","year":"1999","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.ejogrb.2024.07.054_b0075","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0015-0282(97)81908-5","article-title":"Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome","volume":"67","author":"Abramov","year":"1997","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.ejogrb.2024.07.054_b0080","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00404-009-1135-8","article-title":"Regulated expression of the renin-angiotensin-system in human granulosa lutein cells: angiotensin II increases VEGF expression but its synthesis is reduced by hCG","volume":"281","author":"Herr","year":"2010","journal-title":"Arch Gynecol Obstet"},{"issue":"2","key":"10.1016\/j.ejogrb.2024.07.054_b0085","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.fertnstert.2007.12.003","article-title":"Renin-angiotensin system activation during severe OHSS: cause or effect?","volume":"89","author":"Manno","year":"2008","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.ejogrb.2024.07.054_b0090","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1152\/ajprenal.00143.2009","article-title":"The role of calcium in the regulation of renin secretion","volume":"298","author":"Beierwaltes","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"10.1016\/j.ejogrb.2024.07.054_b0095","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1161\/01.HYP.0000250708.04205.d4","article-title":"Decreased intracellular calcium stimulates renin release via calcium-inhibitable adenylyl cyclase","volume":"49","author":"Ortiz-Capisano","year":"2007","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.ejogrb.2024.07.054_b0100","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1161\/HYPERTENSIONAHA.112.196352","article-title":"Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists: a systematic review","volume":"60","author":"Bullo","year":"2012","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.ejogrb.2024.07.054_b0105","article-title":"Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome","volume":"5","author":"D'Angelo","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.ejogrb.2024.07.054_b0110","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1055\/s-0030-1265679","article-title":"Ovarian hyperstimulation syndrome prevention strategies: cryopreservation of all embryos","volume":"28","author":"D'Angelo","year":"2010","journal-title":"Semin Reprod Med"},{"issue":"2","key":"10.1016\/j.ejogrb.2024.07.054_b0115","doi-asserted-by":"crossref","DOI":"10.1093\/hropen\/hoz034","article-title":"The perspective of women with an increased risk of OHSS regarding the safety and burden of IVF: a discrete choice experiment","volume":"2020","author":"Braam","year":"2020","journal-title":"Hum Reprod Open"},{"key":"10.1016\/j.ejogrb.2024.07.054_b0120","article-title":"Comparison of the effectiveness of various medicines in the prevention of ovarian hyperstimulation syndrome: A network meta-analysis of randomized controlled trials","volume":"13","author":"Wu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"10.1016\/j.ejogrb.2024.07.054_b0125","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.fertnstert.2011.04.094","article-title":"Intravenous calcium infusion as a novel preventive therapy of ovarian hyperstimulation syndrome for patients with polycystic ovarian syndrome","volume":"96","author":"Gurgan","year":"2011","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.ejogrb.2024.07.054_b0130","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.fertnstert.2014.09.046","article-title":"Calcium infusion for the prevention of ovarian hyperstimulation syndrome: a double-blind randomized controlled trial","volume":"103","author":"El-Khayat","year":"2015","journal-title":"Fertil Steril"},{"issue":"11","key":"10.1016\/j.ejogrb.2024.07.054_b0135","article-title":"Dopamine agonists for preventing ovarian hyperstimulation syndrome","volume":"11","author":"Tang","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.ejogrb.2024.07.054_b0140","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/87895","article-title":"The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor\/vascular endothelial growth factor","volume":"7","author":"Basu","year":"2001","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.ejogrb.2024.07.054_b0145","doi-asserted-by":"crossref","first-page":"5400","DOI":"10.1210\/en.2006-0657","article-title":"Low-dose dopamine agonist administration blocks vascular endothelial growth factor (VEGF)-mediated vascular hyperpermeability without altering VEGF receptor 2-dependent luteal angiogenesis in a rat ovarian hyperstimulation model","volume":"147","author":"Gomez","year":"2006","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.ejogrb.2024.07.054_b0150","doi-asserted-by":"crossref","first-page":"H1554","DOI":"10.1152\/ajpheart.00272.2004","article-title":"Dopamine in vivo inhibits VEGF-induced phosphorylation of VEGFR-2, MAPK, and focal adhesion kinase in endothelial cells","volume":"287","author":"Sarkar","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"Pt 18","key":"10.1016\/j.ejogrb.2024.07.054_b0155","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1242\/jcs.053124","article-title":"Dopamine regulates phosphorylation of VEGF receptor 2 by engaging Src-homology-2-domain-containing protein tyrosine phosphatase 2","volume":"122","author":"Sinha","year":"2009","journal-title":"J Cell Sci"},{"issue":"7","key":"10.1016\/j.ejogrb.2024.07.054_b0160","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1210\/en.2004-1445","article-title":"Increased pituitary vascular endothelial growth factor-a in dopaminergic D2 receptor knockout female mice","volume":"146","author":"Cristina","year":"2005","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.ejogrb.2024.07.054_b0165","doi-asserted-by":"crossref","first-page":"248","DOI":"10.4103\/0974-1208.126293","article-title":"Calcium gluconate infusion is as effective as the vascular endothelial growth factor antagonist cabergoline for the prevention of ovarian hyperstimulation syndrome","volume":"6","author":"Naredi","year":"2013","journal-title":"J Hum Reprod Sci"},{"issue":"4","key":"10.1016\/j.ejogrb.2024.07.054_b0170","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.mefs.2018.05.001","article-title":"Comparison of cabergoline versus calcium infusion in ovarian hyperstimulation syndrome prevention: A randomized clinical trial","volume":"23","author":"Elnory","year":"2018","journal-title":"Middle East Fertil Soc J"},{"issue":"1","key":"10.1016\/j.ejogrb.2024.07.054_b0175","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1080\/01443615.2020.1870944","article-title":"Cabergoline versus calcium infusion in the prevention of ovarian hyperstimulation syndrome: a randomised controlled study","volume":"42","author":"Fouda","year":"2022","journal-title":"J Obstet Gynaecol"},{"issue":"4","key":"10.1016\/j.ejogrb.2024.07.054_b0180","first-page":"1248","article-title":"Calcium gluconate infusion is not as effective as dopamine agonists in preventing ovarian hyperstimulation syndrome","volume":"26","author":"Turktekin","year":"2022","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"10.1016\/j.ejogrb.2024.07.054_b0185","first-page":"1","article-title":"Calcium dobesilate versus cabergoline for prevention of Ovarian hyper stimulation syndrome","volume":"6","author":"Saad","year":"2017","journal-title":"Reprod Syst Sex Disord: Curr Res"},{"issue":"6","key":"10.1016\/j.ejogrb.2024.07.054_b0190","first-page":"101135","article-title":"Comparative study between calcium gluconate infusion and cabergoline in prevention of ovarian hyperstimulation syndrome in IVF","volume":"20","author":"Wahed","year":"2022","journal-title":"NeuroQuantology"},{"issue":"1","key":"10.1016\/j.ejogrb.2024.07.054_b0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"10","author":"Page","year":"2021","journal-title":"Syst Rev"},{"key":"10.1016\/j.ejogrb.2024.07.054_b0200","unstructured":"Higgins JTPT, of HESECHfsr, Collaboration. ivuMTC, 2011."},{"key":"10.1016\/j.ejogrb.2024.07.054_b0205","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.ejogrb.2024.07.054_b0210","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.ejogrb.2024.07.054_b0215","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"issue":"8","key":"10.1016\/j.ejogrb.2024.07.054_b0220","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/sim.7223","article-title":"Combining randomized and non-randomized evidence in network meta-analysis","volume":"36","author":"Efthimiou","year":"2017","journal-title":"Stat Med"},{"issue":"7109","key":"10.1016\/j.ejogrb.2024.07.054_b0225","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"Br Med J"},{"issue":"8","key":"10.1016\/j.ejogrb.2024.07.054_b0230","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1210\/jc.2011-0075","article-title":"Evidences for the existence of a low dopaminergic tone in polycystic ovarian syndrome: implications for OHSS development and treatment","volume":"96","author":"G\u00f3mez","year":"2011","journal-title":"J Clin Endocrinol Metab"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211524004093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211524004093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T06:54:08Z","timestamp":1728370448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211524004093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":46,"alternative-id":["S0301211524004093"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2024.07.054","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Calcium versus cabergoline for prevention of ovarian hyperstimulation syndrome: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2024.07.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}